JPMorgan Chase & Co. Increases BridgeBio Pharma (NASDAQ:BBIO) Price Target to $45.00 themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Rhumbline Advisers grew its stake in shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO – Free Report) by 1.1% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 179,759 shares of the company’s stock after acquiring an additional 1,924 shares during the period. […]
BridgeBio Pharma (NASDAQ:BBIO – Get Free Report) posted its quarterly earnings results on Thursday. The company reported ($0.96) EPS for the quarter, missing the consensus estimate of ($0.87) by ($0.09), Briefing.com reports. The business had revenue of $1.74 million during the quarter, compared to the consensus estimate of $4.78 million. BridgeBio Pharma’s revenue for the […]
BridgeBio Pharma (NASDAQ:BBIO – Get Free Report) issued its earnings results on Thursday. The company reported ($0.96) EPS for the quarter, missing analysts’ consensus estimates of ($0.87) by ($0.09), Briefing.com reports. The company had revenue of $1.74 million for the quarter, compared to the consensus estimate of $4.78 million. The firm’s revenue for the quarter […]
BridgeBio Pharma, Inc. (NASDAQ:BBIO) Receives $42.00 Average Price Target from Brokerages themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.